benserazide has been researched along with Hypotension in 2 studies
Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.
Hypotension: Abnormally low BLOOD PRESSURE that can result in inadequate blood flow to the brain and other vital organs. Common symptom is DIZZINESS but greater negative impacts on the body occur when there is prolonged depravation of oxygen and nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study describes orthostatic and postprandial hypotension in elderly Parkinsonian patients and evaluates the effect of levodopa therapy on orthostatic and postprandial hypotension in these patients." | 9.09 | Effect of levodopa on orthostatic and postprandial hypotension in elderly Parkinsonian patients. ( Boerman, RH; Hoefnagels, WH; Jansen, RW; Mehagnoul-Schipper, DJ, 2001) |
| "This study describes orthostatic and postprandial hypotension in elderly Parkinsonian patients and evaluates the effect of levodopa therapy on orthostatic and postprandial hypotension in these patients." | 5.09 | Effect of levodopa on orthostatic and postprandial hypotension in elderly Parkinsonian patients. ( Boerman, RH; Hoefnagels, WH; Jansen, RW; Mehagnoul-Schipper, DJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehagnoul-Schipper, DJ | 1 |
| Boerman, RH | 1 |
| Hoefnagels, WH | 1 |
| Jansen, RW | 1 |
| Boudin, G | 1 |
| Pépin, B | 1 |
| Guillard, A | 1 |
| Fabiani, JM | 1 |
| Haguenau, M | 1 |
1 trial available for benserazide and Hypotension
| Article | Year |
|---|---|
Effect of levodopa on orthostatic and postprandial hypotension in elderly Parkinsonian patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Autonomic Nervous System; Benserazide; Blood Pressure | 2001 |
1 other study available for benserazide and Hypotension
| Article | Year |
|---|---|
[Indications and results of monoamine treatment in parkinsonian syndromes].
Topics: Aged; Arrhythmias, Cardiac; Benserazide; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Combinations; | 1972 |